Can AI shrink the billions we spend developing drugs? BioPhy thinks so. It says it knows how to do it.
Related
More from Crazy Stupid Tech
By Om Malik The ink had not even dried on the whopping $500 billion AI Project Stargate when a small meteor hit the planet “AI.” DeepSeek, a company associated with High-Flyer, an $8 billion Chinese hedge fund, released an open-source AI reasoning model, DeepSeek R1. It was immediately seen not only as an attack on OpenAI, the US’s AI giant, but...
By Fred Vogelstein For the past two years - since ChatGPT ignited the modern AI revolution - I’ve wondered aloud to anyone who would listen about when AI was going to enable the large language model of me. Instead of crawling the public internet, it would create a queryable database exclusively based on the digital file cabinets of my personal...
By Om Malik The shift to AI has gotten me back into tinkering mode. A friend pushed me into using Cursor early, and I am using it all the time—not to write apps or create software, but to figure out how things work. Cursor is an AI-enhanced development environment, part of a new category of AI-augmented development tools that differ from...
By Fred Vogelstein When you talk to Jakob Uszkoreit you have to bring your “A“ game. It's not because he's evasive. It's because the stuff he's working on is cutting edge enough that you need every neuron firing to keep up with what he's talking about. Uszkoreit is one of the fathers of modern AI. In 2017 he was one of eight authors of Attention...
By Om MalikMike McCue, the founder of Flipboard, loves the media. He loves reading, watching, and immersing himself in what other Silicon Valley types derisively think of as “content.” McCue, not surprisingly, has spent the past 15 years creating a way to better consume media digitally. He was at ground zero of the web revolution — he worked at...